Close Menu

Writing in the Los Angeles Times, Meryl Comer and Chris Mooney say those worried about mending the economy should consider investing in scientific research. "In a country where 65 percent of the citizens can't name a living scientist and another 18 percent try but get it wrong," Comer and Mooney say that it's a mistake not to ramp up funding for science.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.